CASTLEMAN PETER M has filed 7 insider transactions across 1 company since February 2025.
Most recent transaction: a grant/award of 5509 shares of Caris Life Sciences, Inc. ($CAI) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Caris Life Sciences, Inc. | $CAI | CASTLEMAN PETER M | Director | A | Common Stock | 5509 | $20.06 | 10,395,044.0000 | 297,211,838 | 0.05% | 0.00% |
| Jan. 9, 2026 | Caris Life Sciences, Inc. | $CAI | CASTLEMAN PETER M | Director | M | Common Stock | 2500 | $18.60 | 10,389,535.0000 | 297,211,838 | 0.02% | 0.00% |
| Jan. 9, 2026 | Caris Life Sciences, Inc. | $CAI | CASTLEMAN PETER M | Director | M | Stock Option | 2500 | $0.00 | 0.0000 | 297,211,838 | 100.00% | 0.00% |
| Feb. 27, 2025 | Caris Life Sciences, Inc. | $CAI | CASTLEMAN PETER M | Director | A | Common Stock | 16129 | $0.00 | 10,387,035.0000 | 35,643,589 | 0.16% | 0.05% |
| June 20, 2025 | Caris Life Sciences, Inc. | $CAI | CASTLEMAN PETER M | Director | C | Series A Preferred Stock | 40983607 | $0.00 | 0.0000 | 35,643,589 | 100.00% | 100.00% |
| June 20, 2025 | Caris Life Sciences, Inc. | $CAI | CASTLEMAN PETER M | Director | C | Common Stock | 10245906 | $0.00 | 10,387,035.0000 | 35,643,589 | 7259.96% | 28.75% |
| Feb. 27, 2025 | Caris Life Sciences, Inc. | $CAI | CASTLEMAN PETER M | Director | A | Stock Option | 2500 | $0.00 | 2,500.0000 | 35,643,589 | 9999.99% | 0.01% |